Skip to content
PubMed This is a summary of 5 peer-reviewed journal articles Updated
Neurology

Symptoms and Common Misdiagnoses

At a Glance

ALSP is a rare, progressive brain white-matter disorder that can begin with changes in planning, behavior, language, or movement and may resemble MS, frontotemporal dementia, Alzheimer’s disease, or Parkinsonian disorders. Specialist evaluation and genetic testing can help clarify the diagnosis.

Because ALSP is so rare and its symptoms are so varied, it is frequently mistaken for more common neurological conditions. Research from specific cohorts shows that roughly 75.3% of patients are initially misdiagnosed [1]. For you and your family, understanding the specific ways ALSP manifests—and why it mimics other diseases—can help make sense of the confusing journey to a correct diagnosis.

The Common Domains of ALSP Symptoms

The symptoms of ALSP generally fall into four common domains. While many people eventually experience symptoms from several of these groups, the order in which they appear varies significantly, even between members of the same family, and not everyone develops symptoms in every domain [1][2].

1. Cognitive and Executive Dysfunction

For nearly half of patients in some studies (47.1%), cognitive changes are the first sign of the disease [1]. This isn’t just “forgetfulness”; it usually starts with executive dysfunction—difficulty with complex tasks like planning, organizing, or managing finances [3]. You may notice yourself or your loved one struggling to follow a recipe known for years or failing to keep track of appointments.

2. Psychiatric and Behavioral Changes

About 26.8% of patients first show symptoms that look like psychiatric issues [1]. These can include:

  • Apathy: A profound loss of interest in hobbies, family, or work.
  • Depression or Anxiety: Sudden changes in mood that don’t seem to have an external cause.
  • Disinhibition: Acting impulsively or saying things that are socially inappropriate, which is often a sign of frontal lobe involvement [4].

3. Language Problems (Aphasia)

As the disease progresses, many patients develop aphasia—an impairment of language. In one study, 63% of patients experienced language difficulties [3]. This may start as mild “word-finding” pauses or progress to more significant difficulty communicating through speech. It does not necessarily mean a total inability to communicate, and speech therapy can help maximize communication strategies.

4. Motor and Movement Issues

Motor symptoms can appear early or late in the disease. These often include:

  • Gait Disturbance: Changes in walking, such as shuffling, frequent tripping, or a loss of balance [3].
  • Parkinsonism: This refers to symptoms that look like Parkinson’s disease, such as bradykinesia (slowness of movement), stiffness, or tremors [1].
  • Pyramidal Signs: Weakness or stiffness in the limbs caused by damage to the nerve tracks that carry messages from the brain to the muscles [1].

Why Misdiagnosis is the Norm

Because ALSP symptoms overlap so heavily with other conditions, doctors often reach for the most common explanation first.

If the primary symptom is… The most common misdiagnosis is… Why it is confused with ALSP
Cognitive & Behavioral Frontotemporal Dementia (FTD) Both cause early changes in personality and “executive” brain function in adults [4].
White Matter Lesions Multiple Sclerosis (MS) Both show white spots on an MRI. However, while typical MS is characterized by inflammatory attacks that come and go, MS can also be progressive. Distinguishing between progressive MS and ALSP requires expert clinical evaluation, distinct MRI pattern recognition, and genetic testing [1].
Memory Loss Early-Onset Alzheimer’s In some families, memory loss is more prominent than behavioral changes, mimicking Alzheimer’s [1].
Movement Issues Atypical Parkinson’s The stiffness and slowness of ALSP can look identical to Parkinsonian syndromes [5].
Vascular Changes CADASIL Both are genetic diseases of the white matter, but CADASIL is caused by blood vessel issues rather than immune cell (microglia) failure [1].

How the Disease Progresses

ALSP is generally a progressive disease, though its speed means something different for every person. On average, the disease duration (from onset to severe outcomes or death) in some published cohorts is about 6.8 years, but some patients have lived with the condition for up to 29 years [2].

In some patients, cognitive and daily living skills (like dressing or eating) may decline noticeably over a 24-month period once symptoms become apparent [3]. As the white matter continues to be lost and the brain experiences atrophy (shrinking), physical symptoms like swallowing difficulties (dysphagia) or seizures may emerge [3][1].

It is important to remember that these averages are just statistics from specific study groups, subject to survivor and referral bias. Some individuals remain stable for longer periods, while others may experience a faster decline. This variability is why specialized care and regular monitoring are essential.

Common questions in this guide

What symptoms are common in ALSP?
ALSP can affect thinking and planning, behavior and mood, language, and movement. People may have trouble managing complex tasks, lose interest in activities, develop impulsive behavior, struggle to find words, or experience balance problems, stiffness, slowness, or tremor.
Why can ALSP be mistaken for multiple sclerosis?
Both conditions can produce white spots, or lesions, on a brain MRI. Typical multiple sclerosis often involves inflammatory attacks that come and go, while distinguishing progressive multiple sclerosis from ALSP may require expert review of the clinical history, MRI pattern, and genetic testing.
What other conditions can look like ALSP?
Depending on the first symptoms, ALSP may resemble frontotemporal dementia, early-onset Alzheimer’s disease, atypical Parkinsonian disorders, or CADASIL. Changes in thinking, behavior, memory, movement, or white matter can make these conditions difficult to distinguish without specialist evaluation.
How does ALSP usually progress?
ALSP is generally progressive, but its pace varies considerably from person to person. Some study groups have reported an average disease duration of about 6.8 years, while some people have lived with the condition for much longer; swallowing problems or seizures may develop as the disease advances.
Can speech therapy or physical therapy help with ALSP?
Speech therapy can help a person maintain communication strategies when language becomes difficult. Physical therapy may support walking, balance, strength, and safe movement, with the plan tailored to the person’s abilities and changing needs.
What helps doctors distinguish ALSP from other white-matter diseases?
Doctors consider the pattern and timing of cognitive, behavioral, language, and movement symptoms along with the clinical history. Specialist assessment of MRI findings and genetic testing may help distinguish ALSP from multiple sclerosis and other conditions with similar features.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that many ALSP patients are initially told they have MS, what specific features of my MRI and clinical history distinguish this from MS?
  2. 2.I am experiencing some language trouble. Can we involve a speech-language pathologist early to help preserve communication strategies?
  3. 3.Are the movement issues we are seeing related to the white matter damage, and how can physical therapy help?
  4. 4.How do we track my specific symptoms over time without relying entirely on generic 'average' timelines?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (5)
  1. 1

    Clinical presentation and diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a literature analysis of case studies.

    Papapetropoulos S, Gelfand JM, Konno T, et al.

    Frontiers in neurology 2024; (15()):1320663 doi:10.3389/fneur.2024.1320663.

    PMID: 38529036
  2. 2

    Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation.

    Konno T, Yoshida K, Mizuno T, et al.

    European journal of neurology 2017; (24(1)):37-45 doi:10.1111/ene.13125.

    PMID: 27680516
  3. 3

    Natural History of Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP): A Retrospective Patient Cohort Study.

    Hayer SN, McLaren DG, Nance RM, et al.

    Neurology and therapy 2026; (15(3)):1269-1292 doi:10.1007/s40120-026-00916-0.

    PMID: 41915097
  4. 4

    Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Integrating the literature on hereditary diffuse leukoencephalopathy with spheroids (HDLS) and pigmentary orthochromatic leukodystrophy (POLD).

    Adams SJ, Kirk A, Auer RN

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2018; (48()):42-49 doi:10.1016/j.jocn.2017.10.060.

    PMID: 29122458
  5. 5

    [Adult leukoencephalopathy with axonal spheroids and pigmented glia].

    Rushkevich UN, Pavlovskaya TS, Levshuk ON, et al.

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2025; (125(2)):130-136 doi:10.17116/jnevro2025125021130.

    PMID: 40047845

This page explains ALSP symptoms, possible misdiagnoses, and disease progression for educational purposes only; it does not replace medical advice. A neurologist or other qualified clinician should interpret MRI findings, testing, and changes in function for your situation.

Get notified when new evidence is published on Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.